Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicytokine-based transcriptome-wide association study for 7 inflammatory skin disorders identifies candidate causal genes in keratinocytes.

The Journal of allergy and clinical immunology·2026
Same author

Imbalance of Ciliary Programs Drives Fibroblast Differentiation and Fibrotic Signaling in Systemic Sclerosis.

bioRxiv : the preprint server for biology·2026
Same author

Aurora A kinase activation contributes to the fibrotic phenotype in systemic sclerosis through primary cilia shortening.

Arthritis research & therapy·2026
Same author

Nintedanib attenuates profibrotic gene expression in a 3-dimensional organotypic culture model of systemic sclerosis skin fibrosis.

The Journal of investigative dermatology·2026
Same author

WNT5A induces profibrotic activation of human macrophages via pSTAT3.

Rheumatology (Oxford, England)·2026
Same author

A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model.

JCI insight·2026
Same journal

High-impact Genetic Variants in <i>EGLN1</i>, <i>EPAS1</i>, and Other Genes Identified in Mountaineers by Exome Sequencing.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Review of Potential Diagnostic and Therapeutic Developments in Systemic Lupus Erythematosus (SLE).

Frontiers in bioscience (Scholar edition)·2026
Same journal

The Genetic Feasibility of Gonadal Development and Fertility in Polyodon-Acipenserid Interfamilial Hybrids: An Opinion on the Chromosomal Basis.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Glut1 Acts in Corazonin-Producing Neurons to Regulate Glycogen Storage in <i>Drosophila</i>.

Frontiers in bioscience (Scholar edition)·2026
Same journal

The Evaluation of Neurotrophic Receptor Tyrosine Kinase (NTRK) Alterations in Neuroblastomas.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Molecular Characterization of the Epstein-Barr Virus in Malignant Tumors of Different Origins: An Emphasis on <i>EBER</i> Promoter Value for EBV Classification.

Frontiers in bioscience (Scholar edition)·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

Visualization and Quantification of TGF&#946;/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Transforming growth factor-beta in systemic sclerosis (scleroderma).

John Varga1, Michael L Whitfield

  • 1Feinberg School of Medicine, Northwestern University, Chicago IL, USA. varga@northwestern.edu

Frontiers in Bioscience (Scholar Edition)
|June 2, 2009
PubMed
Summary
This summary is machine-generated.

Transforming growth factor-beta (TGF-beta) drives systemic sclerosis (SSc) pathogenesis. Understanding TGF-beta

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-&#946; Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Experiment Videos

Last Updated: Jun 22, 2026

Visualization and Quantification of TGF&#946;/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-&#946; Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Biology

Background:

  • Systemic sclerosis (SSc) is a chronic connective tissue disease marked by fibrosis.
  • Deregulated transforming growth factor-beta (TGF-beta) signaling is central to SSc pathogenesis.
  • SSc exhibits heterogeneous clinical manifestations and molecular subtypes.

Purpose of the Study:

  • To investigate the role of TGF-beta in regulating fibroblast function in SSc.
  • To explore potential targeted therapies for SSc based on TGF-beta pathways.
  • To understand the molecular signatures underlying SSc heterogeneity.

Main Methods:

  • Transcriptional profiling of gene expression in SSc target organs.
  • Analysis of TGF-beta signaling pathways in fibroblasts.
  • Investigating fibroblast function in the context of SSc.

Main Results:

  • TGF-beta activity and responses are key contributors to SSc.
  • Fibroblast function is significantly regulated by TGF-beta.
  • Distinct molecular signatures define SSc subgroups.

Conclusions:

  • Targeted therapies blocking TGF-beta signaling are promising for SSc treatment.
  • Further research into TGF-beta's role in SSc may yield novel anti-fibrotic strategies.
  • Understanding molecular subtypes is crucial for personalized SSc treatment.